SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Michael E. Egger, Lacey R. McNally, Jonathan Nitz, Kelly M. McMasters, Jorge G. Gomez-Gutierrez, Adenovirus-MediatedFKHRL1/TMSensitizes Melanoma Cells to Apoptosis Induced by Temozolomide, Human Gene Therapy Clinical Development, 2014, 25, 3, 186

    CrossRef

  2. 2
    Hye Jin Chung, Meera Mahalingam, Angiogenesis, vasculogenic mimicry and vascular invasion in cutaneous malignant melanoma – implications for therapeutic strategies and targeted therapies, Expert Review of Anticancer Therapy, 2014, 14, 5, 621

    CrossRef

  3. 3
    Michelle T. Ashworth, Adil I. Daud, Combinatorial Approach to Treatment of Melanoma, Hematology/Oncology Clinics of North America, 2014, 28, 3, 601

    CrossRef

  4. 4
    Chiara Dianzani, Gian Paolo Zara, Giovanni Maina, Piergiorgio Pettazzoni, Stefania Pizzimenti, Federica Rossi, Casimiro Luca Gigliotti, Eric Stefano Ciamporcero, Martina Daga, Giuseppina Barrera, Drug Delivery Nanoparticles in Skin Cancers, BioMed Research International, 2014, 2014, 1

    CrossRef

  5. 5
    N Dey, P De, B Leyland-Jones, Evading anti-angiogenic therapy: resistance to anti-angiogenic therapy in solid tumours, British Journal of Cancer, 2014,

    CrossRef

  6. 6
    Darshil J. Shah, Roxana S. Dronca, Latest Advances in Chemotherapeutic, Targeted, and Immune Approaches in the Treatment of Metastatic Melanoma, Mayo Clinic Proceedings, 2014, 89, 4, 504

    CrossRef

  7. 7
    I. Pastushenko, P.B. Vermeulen, G.G. Van den Eynden, A. Rutten, F.J. Carapeto, L.Y. Dirix, S. Van Laere, Mechanisms of tumour vascularization in cutaneous malignant melanoma: clinical implications, British Journal of Dermatology, 2014, 171, 2
  8. 8
    David Kudlowitz, Franco Muggia, Nanoparticle albumin-bound paclitaxel (nab-paclitaxel): extending its indications, Expert Opinion on Drug Safety, 2014, 1

    CrossRef

  9. 9
    Erika Vacchelli, Fernando Aranda, Alexander Eggermont, Jérôme Galon, Catherine Sautès-Fridman, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi, Trial Watch, OncoImmunology, 2014, 3, 1, e27048

    CrossRef

  10. 10
    Lucio Tentori, Pedro Miguel Lacal, Grazia Graziani, Challenging resistance mechanisms to therapies for metastatic melanoma, Trends in Pharmacological Sciences, 2013, 34, 12, 656

    CrossRef

  11. 11
    Aaron S. Mansfield, Svetomir N. Markovic, Inhibition of Angiogenesis for the Treatment of Metastatic Melanoma, Current Oncology Reports, 2013, 15, 5, 492

    CrossRef

  12. 12
    Dionysis Papadatos-Pastos, Adam Januszewski, Angus Dalgleish, Revisiting the role of systemic therapies in patients with metastatic melanoma to the CNS, Expert Review of Anticancer Therapy, 2013, 13, 5, 559

    CrossRef

  13. 13
    Aaron S. Mansfield, Wendy K. Nevala, Elizabeth Ann T. Lieser, Alexey A. Leontovich, Svetomir N Markovic, The immunomodulatory effects of bevacizumab on systemic immunity in patients with metastatic melanoma, OncoImmunology, 2013, 2, 5, e24436

    CrossRef

  14. 14
    Jo Marie Tran Janco, Svetomir N. Markovic, Amy L. Weaver, William A. Cliby, Vulvar and vaginal melanoma: Case series and review of current management options including neoadjuvant chemotherapy, Gynecologic Oncology, 2013, 129, 3, 533

    CrossRef